Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-35027061

RESUMO

BACKGROUND: The impacts of the COVID-19 pandemic have been vast and are not limited to physical health. Many adolescents have experienced disruptions to daily life, including changes in their school routine and family's financial or emotional security, potentially impacting their emotional wellbeing. In low COVID-19 prevalence settings, the impact of isolation has been mitigated for most young people through continued face-to-face schooling, yet there may still be significant impacts on their wellbeing that could be attributed to the pandemic. METHODS: We report on data from 32,849 surveys from Year 7-12 students in 40 schools over two 2020 survey cycles (June/July: 19,240; October: 13,609), drawn from a study of 79 primary and secondary schools across Western Australia, Australia. The Child Health Utility Index (CHU9D) was used to measure difficulties and distress in responding secondary school students only. Using comparable Australian data collected six years prior to the pandemic, the CHU9D was calibrated against the Kessler-10 to establish a reliable threshold for CHU9D-rated distress. RESULTS: Compared to 14% of responding 12-18-year-olds in 2013/2014, in both 2020 survey cycles almost 40% of secondary students returned a CHU9D score above a threshold indicative of elevated difficulties and distress. Student distress increased significantly between June and October 2020. Female students, those in older Grades, those with few friendships or perceived poor quality friendships, and those with poor connectedness to school were more likely to score above the threshold. CONCLUSIONS: In a large dataset collected during the first year of the COVID-19 pandemic, the proportion of secondary school students with scores indicative of difficulties and distress was substantially higher than a 2013/2014 benchmark, and distress increased as the pandemic progressed, despite the low local prevalence of COVID-19. This may indicate a general decline in social and emotional wellbeing exacerbated by the events of the pandemic. TRIAL REGISTRATION: ANZCTRN (ACTRN12620000922976). Retrospectively registered 17/08/2020. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380429&isReview=true .

2.
Public Health ; 178: 82-89, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31644986

RESUMO

OBJECTIVES: To our knowledge, there has been limited description of emergency department (ED) visits involving homeless patients over the last decade. Our study aims to analyze US national survey data to elucidate the differences between homeless and non-homeless patients' ED visits in terms of patient demographics, resource utilization, and diagnoses received. STUDY DESIGN: This was a retrospective study using data from the National Hospital Ambulatory Medical Care Survey (NHAMCS) from 2005 until 2015. METHODS: Patient visits were classified as homeless or non-homeless based on survey data; appropriate statistical analyses were subsequently performed to compare these groups in terms of patient demographics, geography, payment method, resource utilization/diagnostic service use, as well as both psychiatric and non-psychiatric diagnoses received in the ED. RESULTS: NHAMCS data from 2005 to 2015 were aggregated. In total, 303,326 patient visits were included, which represent an estimated 1.30 billion ED visits over this period. Of these, 2750 encounters were by homeless people, representing 8,781,925 ED visits. Compared with non-homeless visits, homeless patients were disproportionately male, black, non-Hispanic, and seen in large metropolitan areas or the Western/Southern US. Homeless visits were more likely to be related to an injury (47.5% vs. 33.8%), related to an assault (4.2% vs. 1.3%), or self-inflicted (4.8% vs 0.84%). Homeless patients were also more likely to have been seen in the same ED within 72 h (7.3% vs. 3.9%) compared with non-homeless patients (3.9%, 95% confidence interval [CI]: 3.5-4.4) and were seen an average of 5.7 times (95% CI: 4.7-6.8) in the same ED over the preceding 12 months, with non-homeless patients seen an average of 3.2 times (95% CI: 3.1-3.4). Homeless patients were more likely to be admitted to the hospital (14.9% vs. 11.2%) and, when admitted, spent an average of 6.3 days in the hospital (95% CI: 5.6-7.1) compared with non-homeless patients at 5.2 (95% CI: 5.1-5.3). In total, 28.4% of homeless patients received a psychiatric diagnosis (95% CI: 25.8-31.2) compared with 5.4% for non-homeless patients (95% CI: 5.2-5.7, P < 0.001). In reference to non-homeless visits, homeless visits showed increased odds of alcohol-related diagnoses (odds ratio [OR]: 17.3, 95% CI: 10.1-29.8, P < 0.001) and substance abuse diagnoses (OR: 8.4, 95% CI: 7.2-9.8, P < 0.001). Homeless visits also exhibited greatly increased odds of diagnosis of schizophrenia (OR: 16.6, 95% CI: 12.6-22.5, P < 0.001) and personality disorders (OR: 15.4, 95% CI: 6.4-36.9, P < 0.001). CONCLUSIONS: Less than one in 100 US ED visits in 2005-2015 were made by homeless patients. Compared with the non-homeless, homeless patients had greatly increased rates of ED care for alcohol-related, substance abuse-related, and mental health-related problems, particularly schizophrenia and personality disorders. Homeless patients were also more likely to be seen in the ED within the past 72 h or the past 12 months. Homeless patients were more likely to be admitted to the hospital and, when admitted, exhibited longer stay times.


Assuntos
Serviço Hospitalar de Emergência/estatística & dados numéricos , Pessoas Mal Alojadas/estatística & dados numéricos , Adolescente , Adulto , Idoso , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Estados Unidos , Adulto Jovem
3.
J Vet Pharmacol Ther ; 34(6): 583-7, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21323676

RESUMO

The intravenous pharmacokinetic profile of tilmicosin is yet to be achieved because of the cardiovascular effects of tilmicosin. This study summarizes two pharmacokinetic studies that provided complete pharmacokinetic profile of tilmicosin in cattle. The first study was a pharmacokinetic study of tilmicosin in beef calves dosed by i.v. infusion over 5 h. The second study was a subcutaneous (s.c.) pharmacokinetic study comparing the pharmacokinetic profile of tilmicosin in light (approximately 170 kg) and heavy (approximately 335 kg) beef cattle and comparing the labeled dose range of 10 or 20 mg/kg dose. The data from the two different studies were used to calculate bioavailability values, which support the assumption that tilmicosin is 100% bioavailable in cattle. The results from the second study showed that the weight of an animal when administered tilmicosin does not have a significant effect on exposure, but did demonstrate that doubling the dose of tilmicosin administered doubles the systemic exposure to tilmicosin.


Assuntos
Antibacterianos/farmacocinética , Bovinos/sangue , Tilosina/análogos & derivados , Animais , Antibacterianos/administração & dosagem , Antibacterianos/sangue , Disponibilidade Biológica , Peso Corporal , Cromatografia Líquida de Alta Pressão/veterinária , Relação Dose-Resposta a Droga , Feminino , Infusões Intravenosas/veterinária , Injeções Subcutâneas/veterinária , Espectrometria de Massas em Tandem/veterinária , Tilosina/administração & dosagem , Tilosina/sangue , Tilosina/farmacocinética
5.
J Am Acad Dermatol ; 39(3): 447-50, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9738781

RESUMO

BACKGROUND: Weekend therapy with superpotent topical corticosteroids has been used for the long-term treatment of psoriasis. Recently, calcipotriene ointment has been added to this regimen for use on weekdays, but there are no long-term studies of that combination. OBJECTIVE: The purpose of this study was to determine whether the addition of weekday calcipotriene to a pulse therapy regimen of weekend superpotent corticosteroids results in a longer duration of remission of plaque psoriasis. SUBJECTS: This was a double-blind, placebo-controlled, parallel-group study. Forty-four patients with mild to moderate psoriasis were treated with calcipotriene ointment in the morning and halobetasol ointment in the evening for 2 weeks. Thereafter, 40 patients who were at least moderately (50% or greater) improved were randomized to 2 treatment groups. After 2 weeks of treatment with calcipotriene ointment in the morning and halobetasol ointment in the evening, 20 patients were randomized to receive halobetasol ointment twice daily on weekends and calcipotriene ointment twice daily on weekdays, and 20 patients were randomized to receive halobetasol ointment twice daily on weekends and placebo ointment twice daily on weekdays. RESULTS: Seventy-six percent of patients applying halobetasol ointments on weekends and calcipotriene ointment on weekdays were able to maintain remission for 6 months compared with 40% of patients applying halobetasol ointment on weekends only with the vehicle on weekdays. CONCLUSION: The addition of calcipotriene ointment applied on weekdays to a weekend pulse therapy regimen of superpotent corticosteroids can increase the duration of remission of psoriasis.


Assuntos
Calcitriol/análogos & derivados , Clobetasol/análogos & derivados , Fármacos Dermatológicos/administração & dosagem , Psoríase/tratamento farmacológico , Administração Tópica , Adulto , Calcitriol/administração & dosagem , Clobetasol/administração & dosagem , Método Duplo-Cego , Esquema de Medicação , Humanos , Pomadas , Fatores de Tempo
7.
Psychoanal Rev ; 77(4): 573-85, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-1708152

RESUMO

Greenberg and Mitchell (1983) have suggested that the drive/structure model and the relational/structure model are mutually exclusive models of psychic life. We regard their contribution as an invaluable one, which makes explicit the fundamental divergences in psychoanalytic theory. We have examined a derivative tendency in the field, for drive and relational theorists alike, to present psychic life as a dichotomy between inner experience and outer experience. We see a tendency to equate the drive model with unconscious motivation, and to the primacy of internal experience. There seems to be an equivalent tendency to equate the relational model with conscious perception and motivation, and to the primacy of external experience. We are advocating, for drive and relational theorists alike, greater focus on the process of intermediation between internal and external experience in the psychic life of the individual. Within the context of the drive model, precedent for such a focus is found in Freud's conception of the preconscious, an essential third dimension whose function was to mediate between the conscious and the unconscious. Within the context of the relational model, Winnicott's notion of potential space serves as a bridge between interior experience and external reality in the life of the individual. Finally, we have argued that by constructing three-part models of psychic life, these theorists have laid the groundwork for a synthetic theory. Though for Freud the drive state is primary, and for Winnicott the relationship between the infant and its environment (mother) is primary, each theorist posits an intermediating zone that fulfills a similar function in the psychic life of the individual. Whether we choose to call that zone the preconscious or potential space, its function is to translate bidirectionally between the infinitely dimensioned realm of interior, or unconscious, experience and the time-and space-bound realm of external, or conscious, experience. By highlighting the parallel constructs, we are not claiming to have created a synthesis between the theories. Our claim is that the eventual road to synthesis appears to reside in the direction of a movement away from the dichotomy between the primacy of inner or outer experience, and toward the common meeting ground of the primacy of an intermediating function.


Assuntos
Impulso (Psicologia) , Apego ao Objeto , Desenvolvimento da Personalidade , Teoria Psicanalítica , Inconsciente Psicológico , Teoria Freudiana , Humanos , Simbolismo
8.
Percept Mot Skills ; 55(3 Pt 2): 1063-70, 1982 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7167292

RESUMO

32 left-handed and 34 right-handed college educated women were administered a hemispheric lateralization task and measures of physiognomic perception and cognitive flexibility. Results supported the hypothesis that differing hemispheric lateralization patterns would be reflected in differing degrees of physiognomic perception and flexibility of cognitive control. The demonstrated relationships suggest possible structural parallels between hemispheric lateralization patterns and cognitive style. Results further suggest that ambilateralization, rather than reducing hemispheric efficiency, may be a more advantageous psychological organization for certain cognitive tasks.


Assuntos
Cognição , Dominância Cerebral , Percepção de Forma , Reconhecimento Visual de Modelos , Percepção de Cores , Face , Feminino , Humanos , Resolução de Problemas , Semântica , Percepção da Fala
9.
Nucleic Acids Res ; 1(11): 1497-502, 1974 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10793705

RESUMO

Bacteriophage PBS2 replication is unaffected by rifampicin and other rifamycin derivatives, which are potent inhibitors of Bacillus subtilis RNA synthesis. Extracts of gently-lysed infected cells contain a DNA-dependent RNA polymerase activity which is specific for uracil-containing PBS2 DNA. The PBS2-induced RNA polymerase is insensitive to rifamycin derivatives which inhibit the host's RNA polymerase.


Assuntos
Aminoglicosídeos , Fagos Bacilares/efeitos dos fármacos , Bacillus subtilis/virologia , RNA Polimerases Dirigidas por DNA/metabolismo , Rifampina/farmacologia , Proteínas Virais/metabolismo , Antibacterianos/farmacologia , Fagos Bacilares/enzimologia , Fagos Bacilares/fisiologia , Bacillus subtilis/enzimologia , Cloranfenicol/farmacologia , RNA Polimerases Dirigidas por DNA/antagonistas & inibidores , Dactinomicina/farmacologia , Resistência Microbiana a Medicamentos , Lucantona/farmacologia , Rifamicinas/farmacologia , Estreptovaricina/farmacologia , Proteínas Virais/antagonistas & inibidores , Replicação Viral/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...